Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report
暂无分享,去创建一个
E. Georgakopoulou | D. Tryfonopoulos | I. Gkouveris | S. Ioannou | P. Gouveris | D. Zouki | S. Demiri | A. Grigoraki | V. Kardara
[1] A. Alessandrini,et al. Oral Manifestations in Melanoma Patients Treated with Target or Immunomodulatory Therapies , 2021, Journal of clinical medicine.
[2] R. Motzer,et al. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. , 2020, Cancer.
[3] R. Mesquita,et al. Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus. , 2020, Oral diseases.
[4] S. Fitzpatrick,et al. Lichenoid reaction with granulomatous stomatitis: a retrospective histologic study of 47 patients. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[5] H. Nakatani,et al. Drug-induced oral lichenoid reaction during nivolumab therapy. , 2019, International journal of oral and maxillofacial surgery.
[6] J. Diaz-Perez,et al. Granulomatous and lichenoid dermatitis after IgG4 anti‐PD‐1 monoclonal antibody therapy for advanced cancer , 2018, Journal of cutaneous pathology.
[7] Y. Amoh,et al. Oral lichenoid reaction showing multiple ulcers associated with anti‐programmed death cell receptor‐1 treatment: A report of two cases and published work review , 2018, The Journal of dermatology.
[8] K. Rieger,et al. Granuloma annulare associated with immune checkpoint inhibitors , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[9] R. Motzer,et al. Oral lichenoid reactions associated with anti‐PD‐1/PD‐L1 therapies: clinicopathological findings , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[10] C. Lombard,et al. Nivolumab-Induced Granulomatous Inflammation of the Pleura. , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] J. Epstein,et al. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors , 2017, Supportive Care in Cancer.
[12] H. Yokozeki,et al. Severe Oral Ulcers Associated With Nivolumab Treatment. , 2017, JAMA dermatology.
[13] S. Gettinger,et al. Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy. , 2016, JAMA dermatology.
[14] J. Utikal,et al. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. , 2016, European journal of cancer.
[15] L. Vercellino,et al. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma. , 2016, Chest.
[16] R. Novoa,et al. Immunohistochemical analysis of lichenoid reactions in patients treated with anti‐PD‐L1 and anti‐PD‐1 therapy , 2016, Journal of cutaneous pathology.
[17] Spring Golden,et al. New-onset oral lichen planus and granulomatous cheilitis in a 66-year-old woman , 2016, JAAD case reports.
[18] A. Amin,et al. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities. , 2015, Translational lung cancer research.
[19] A. Errico. Immunotherapy: PD-1–PD-L1 axis: efficient checkpoint blockade against cancer , 2015, Nature Reviews Clinical Oncology.
[20] J. Saurat,et al. Giant cell lichenoid dermatitis in a patient with baboon syndrome , 2008, Journal of cutaneous pathology.
[21] J. Oxley,et al. Lichenoid and granulomatous stomatitis: an entity or a non-specific inflammatory process? , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[22] D. James. A clinicopathological classification of granulomatous disorders , 2000, Postgraduate medical journal.
[23] C. Magro,et al. Lichenoid and granulomatous dermatitis , 2000, International journal of dermatology.
[24] M. D. Marcus,et al. Giant cell lichenoid dermatitis. , 1986, Journal of the American Academy of Dermatology.